Carbocisteine inhibits rhinovirus infection in human tracheal epithelial cells Source: Eur Respir J 2006; 28: 51-58 Year: 2006
Free, soluble interleukin-17 protein during severe inflammation in human airways Source: Eur Respir J 2002; 19: 534-537 Year: 2002
TD-0903, an inhaled JAK inhibitor in development for COVID-19, blocks ARDS-relevant hyperinflammation and lung injury in primary human immune and airway epithelial cells Source: Virtual Congress 2021 – Emerging respiratory diseases: state-of-the-art studies of SARS-CoV-2 infection Year: 2021
The potent and lung-selective inhaled pan JAK inhibitor TD-8236 limits airway inflammation without affecting systemic immunity in mice Source: International Congress 2019 – Novel targets and mechanisms in asthma Year: 2019
A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection Source: Lung Science Conference 2015 Year: 2015
LATE-BREAKING ABSTRACT: RV568, a narrow spectrum kinase inhibitor (NSKI), inhibits virus induced nasal interleukin-8 (IL8) in the human viral challenge model where healthy adult male volunteers were experimentally inoculated with live respiratory syncytial virus Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment Year: 2013
Inhibitory effects of tiotropium on rhinovirus infection in human airway epithelial cells Source: Eur Respir J 2012; 40: 122-132 Year: 2012
Physiomer(R) reduces the chemokine interleukin-;8 production by activated human respiratory epithelial cells Source: Eur Respir J 2001; 18: 661-666 Year: 2001
Rhinovirus induces airway fibroblast release of neutrophil but not eosinophil chemokines Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections Year: 2005
Secretory leucoprotease inhibitor (SLPI) inhibits IL-8 expression induced by double-stranded RNA in airway epithelial cells Source: Annual Congress 2008 - Airway cell biology Year: 2008
Fluticasone reduces IL-6 and IL-8 production of cystic fibrosis bronchial epithelial cells via IKK-β kinase pathway Source: Eur Respir J 2003; 21: 574-581 Year: 2003
LSC Abstract – A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015
Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma Source: Eur Respir J 2002; 19: 68-75 Year: 2002
The effect of sputum processing on tumour necrosis factor (TNFα), secretory leukoprotease inhibitor (SLPI), interleukin-6 and leukotriene-B4 (LTB4 ) in chronic bronchitis and bronchiectasis Source: Eur Respir J 2001; 18: Suppl. 33, 364s Year: 2001
Effect of clarithromycin on rhinovirus-16 infection in A549 cells Source: Eur Respir J 2006; 27: 12-19 Year: 2006
Azithromycin (AZI) inhibits the IL-17 induced IL-8 production in human airway smooth muscle cells (HASMC): a possible explanation for the beneficial effect in BOS? Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation Year: 2005
Naphthoquinone enhances antigen-related airway inflammation in mice Source: Eur Respir J 2007; 29: 259-267 Year: 2007
IL-33 may augment the effect of rhinovirus HRV16 on the inflammatory activity of human lung vascular endothelium – possible implication for asthma exacerbations. Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021
Role of macrophage migration inhibitory factor in ovalbumin-induced airway inflammation in rats Source: Eur Respir J 2006; 27: 726-734 Year: 2006
Recombinant human pulmonary surfactant protein-D (rhSP-D) modulates Th2 responses and suppresses IgE-facilitated allergen binding to B cells Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy Year: 2013